CPG 7909 + Local Radiotherapy in Recurrent Low-Grade Lymphomas
Trial ID or NCT#
NCT00185965
Status
NOT RECRUITING
Purpose
Brief summary TBD
Official Title
Le23 CPG: A Phase 1-2 Study of Intratumoral Injection of CPG 7909, A TLR 9 Agonist, Combined With Local Radiation in Recurrent Low-Grade Lymphomas
Investigator(s)
Ronald Levy, MD
Medical oncologist,
Lymphoma specialist
Robert K. and Helen K. Summy Professor in the School of Medicine
Contact us to find out if this trial is right for you.
Contact
Cameron Harrison
6507217186
View on ClinicalTrials.gov
